| Aegis Logistics |
Aegis Logistics Limited announced that its board approved the acquisition of an 89.8% stake in Tristar Holdings Limited for a consideration of US$809 million, including contingent and interest for deferred consideration, via its 100% step-down subsidiary, Aegis Logistics International Pte Ltd. Tristar, incorporated in Dubai, is an integrated liquid logistics solutions provider with operations in over 30 countries and generated approximately US$1.4 billion in revenue for the fiscal year ended December 31, 2025. The acquisition, not considered a related party transaction, is expected to be completed in Q4 FY27 and is subject to regulatory approvals. |
| Auto.Corp.of Goa |
Automobile Corporation of Goa Limited will hold a board meeting on Wednesday, October 21, 2026, to consider and approve the audited financial results for the quarter and half year ended September 30, 2026, along with the reports of the auditors, the company said in a filing with the BSE Limited. The company has closed its trading window for designated persons from September 23, 2026, and it will remain closed until 48 hours after the publication of the financial results. |
| Sanathnagar Ent. |
Sanathnagar Enterprises Limited will hold a board meeting on October 21, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, along with a limited review report. Trading in the company's shares, with Scrip Code 509423, has been suspended from October 1, 2026, until 48 hours after the financial results are released. |
| Batliboi |
Bhogilal Industries is seeking shareholder approval to allot 19,31,699 shares to Mr. Nirmal Bhogilal, a promoter group member, in exchange for settling an existing loan, increasing his stake from 29.75% to 32.51% of the company’s outstanding shares. The allotment, detailed in a notice for the upcoming Annual General Meeting, will not trigger a change in control and will be subject to SEBI lock-in regulations, with a valuation report from CA Harsh Chandrakant Ruparelia used to determine the share price. Additionally, the company plans to appoint Mr. Shankaran Rajaram Vignesh as an additional independent director for a five-year term, beginning October 7, 2026. The company confirmed that neither it nor its promoters are classified as wilful defaulters or fugitive economic offenders, and the share allotment is being reviewed under SEBI’s Substantial Acquisition of Shares and Takeovers regulations. |
| Glaxosmi. Pharma |
GlaxoSmithKline Pharmaceuticals Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, the company said in a filing to the BSE Limited and the National Stock Exchange of India Limited. |